An efficient, practical, asymmetric synthesis of the endothelin receptor an
tagonist 1 is reported. The key pyridine-fused cyclopentane ring bearing th
ree consecutive chiral centers was constructed by first an auxiliary induce
d asymmetric conjugate addition of the bottom aryllithium from 19 to an uns
aturated ester 21 in high diastereoselectivity. After a highly diastereosel
ective addition of the top aryl Grignard reagent to the aldehyde 22, the al
cohol product then underwent a stereospecific intramolecular alkylation of
the eater enolate by the phosphate of the alcohol, resulting in the desired
trans-trans relative stereochemistry on the cyclopentane ring. The two key
chiral centers that set the chirality of the molecule were both induced fr
om cis-1-amino-2-indanol-derived chiral auxiliaries, one in the conjugate a
ddition reaction, the other in setting the chiral center of the bottom side
chain via chiral alkylation of an enolate. Oxidation of the primary alcoho
l to the carboxylic acid in the bottom side chain was carried out with the
newly developed TEMPO/bleach-catalyzed oxidation by sodium chlorite (NaClO2
) or chromium oxide catalyzed oxidation by periodic acid. The overall proce
ss has been run successfully to make multikilograms of the drug in high pur
ity.